120 related articles for article (PubMed ID: 33442529)
1. Molecular docking studies of gyrase inhibitors: weighing earlier screening bedrock.
Kumar HSS; Kumar SR; Kumar NN; Ajith S
In Silico Pharmacol; 2021; 9(1):2. PubMed ID: 33442529
[TBL] [Abstract][Full Text] [Related]
2. Identification of new DNA gyrase inhibitors based on bioactive compounds from streptomyces: structure-based virtual screening and molecular dynamics simulations approaches.
Kalhor H; Sadeghi S; Marashiyan M; Kalhor R; Aghaei Gharehbolagh S; Akbari Eidgahi MR; Rahimi H
J Biomol Struct Dyn; 2020 Feb; 38(3):791-806. PubMed ID: 30916622
[TBL] [Abstract][Full Text] [Related]
3. Virtual Screening of Novel Glucosamine-6-Phosphate Synthase Inhibitors.
Lather A; Sharma S; Khatkar A
Comb Chem High Throughput Screen; 2018; 21(3):182-193. PubMed ID: 29600755
[TBL] [Abstract][Full Text] [Related]
4. Novel 1,2,4-oxadiazole-chalcone/oxime hybrids as potential antibacterial DNA gyrase inhibitors: Design, synthesis, ADMET prediction and molecular docking study.
Ibrahim TS; Almalki AJ; Moustafa AH; Allam RM; Abuo-Rahma GEA; El Subbagh HI; Mohamed MFA
Bioorg Chem; 2021 Jun; 111():104885. PubMed ID: 33838559
[TBL] [Abstract][Full Text] [Related]
5. Anti-tubercular Modelling via QSAR Approach, In Silico Design and Virtual Docking Screening of Designed Hypothetical Inhibitors Against DNA gyrase Protein.
Adeniji SE
Curr Comput Aided Drug Des; 2021; 17(6):739-758. PubMed ID: 32586260
[TBL] [Abstract][Full Text] [Related]
6. Discovery of New Schiff Bases Tethered Pyrazole Moiety: Design, Synthesis, Biological Evaluation, and Molecular Docking Study as Dual Targeting DHFR/DNA Gyrase Inhibitors with Immunomodulatory Activity.
Hassan AS; Askar AA; Naglah AM; Almehizia AA; Ragab A
Molecules; 2020 Jun; 25(11):. PubMed ID: 32498469
[TBL] [Abstract][Full Text] [Related]
7. Pharmacore maping based on docking, ADME/toxicity, virtual screening on 3,5-dimethyl-1,3,4-hexanetriol and dodecanoic acid derivates for anticancer inhibitors.
Prakash P; Vijayasarathi D; Selvam K; Karthi S; Manivasagaperumal R
J Biomol Struct Dyn; 2021 Aug; 39(12):4490-4500. PubMed ID: 32567489
[TBL] [Abstract][Full Text] [Related]
8. Docking-based virtual screening of Brazilian natural compounds using the OOMT as the pharmacological target database.
Carregal AP; Maciel FV; Carregal JB; Dos Reis Santos B; da Silva AM; Taranto AG
J Mol Model; 2017 Apr; 23(4):111. PubMed ID: 28285443
[TBL] [Abstract][Full Text] [Related]
9. Identification and Molecular Docking Studies of Bioactive Principles from Alphonsea madraspatana Bedd. against Uropathogens.
Sahu A; Ghosh G; Rath G
Curr Pharm Biotechnol; 2020; 21(7):613-625. PubMed ID: 31914910
[TBL] [Abstract][Full Text] [Related]
10. Discovery of Novel Mycobacterial DNA Gyrase B Inhibitors: In Silico and In Vitro Biological Evaluation.
Saxena S; Renuka J; Yogeeswari P; Sriram D
Mol Inform; 2014 Sep; 33(9):597-609. PubMed ID: 27486079
[TBL] [Abstract][Full Text] [Related]
11. Identification of chebulinic acid as potent natural inhibitor of M. tuberculosis DNA gyrase and molecular insights into its binding mode of action.
Patel K; Tyagi C; Goyal S; Jamal S; Wahi D; Jain R; Bharadvaja N; Grover A
Comput Biol Chem; 2015 Dec; 59 Pt A():37-47. PubMed ID: 26410242
[TBL] [Abstract][Full Text] [Related]
12. Novel 2-arylbenzothiazole DNA gyrase inhibitors: Synthesis, antimicrobial evaluation, QSAR and molecular docking studies.
Ghannam IAY; Abd El-Meguid EA; Ali IH; Sheir DH; El Kerdawy AM
Bioorg Chem; 2019 Dec; 93():103373. PubMed ID: 31698294
[TBL] [Abstract][Full Text] [Related]
13. Molecular Modeling Studies of Novel Fluoroquinolone Molecules.
Allaka TR; Katari NK; Veeramreddy V; Anireddy JS
Curr Drug Discov Technol; 2018; 15(2):109-122. PubMed ID: 28875852
[TBL] [Abstract][Full Text] [Related]
14. Experimental and Molecular Docking Studies of Cyclic Diphenyl Phosphonates as DNA Gyrase Inhibitors for Fluoroquinolone-Resistant Pathogens.
Saleh NM; Moemen YS; Mohamed SH; Fathy G; Ahmed AAS; Al-Ghamdi AA; Ullah S; El Sayed IE
Antibiotics (Basel); 2022 Jan; 11(1):. PubMed ID: 35052930
[TBL] [Abstract][Full Text] [Related]
15. Structure based drug discovery and in vitro activity testing for DNA gyrase inhibitors of Salmonella enterica serovar Typhi.
Sharma P; Kumar M; Dahiya S; Sood S; Das BK; Kaur P; Kapil A
Bioorg Chem; 2020 Nov; 104():104244. PubMed ID: 32966903
[TBL] [Abstract][Full Text] [Related]
16. Pharmacophore-Based Virtual Screening and Molecular Dynamics Simulation for Identification of a Novel DNA Gyrase B Inhibitor with Benzoxazine Acetamide Scaffold.
Elseginy SA; Anwar MM
ACS Omega; 2022 Jan; 7(1):1150-1164. PubMed ID: 35036778
[TBL] [Abstract][Full Text] [Related]
17. Discovery of novel DNA gyrase inhibitors by high-throughput virtual screening.
Ostrov DA; Hernández Prada JA; Corsino PE; Finton KA; Le N; Rowe TC
Antimicrob Agents Chemother; 2007 Oct; 51(10):3688-98. PubMed ID: 17682095
[TBL] [Abstract][Full Text] [Related]
18. Computational Approaches to Develop Isoquinoline Based Antibiotics through DNA Gyrase Inhibition Mechanisms Unveiled through Antibacterial Evaluation and Molecular Docking.
Alagumuthu M; Muralidharan VP; Andrew M; Ahmed MH; Iyer SK; Arumugam S
Mol Inform; 2018 Dec; 37(12):e1800048. PubMed ID: 30051592
[TBL] [Abstract][Full Text] [Related]
19. Design, synthesis, in vitro antimicrobial evaluation and molecular docking studies of indol-2-one tagged with morpholinosulfonyl moiety as DNA gyrase inhibitors.
Salem MA; Ragab A; El-Khalafawy A; Makhlouf AH; Askar AA; Ammar YA
Bioorg Chem; 2020 Mar; 96():103619. PubMed ID: 32036161
[TBL] [Abstract][Full Text] [Related]
20. Antibacterial Evaluation and Virtual Screening of New Thiazolyl-Triazole Schiff Bases as Potential DNA-Gyrase Inhibitors.
Nastasă C; Vodnar DC; Ionuţ I; Stana A; Benedec D; Tamaian R; Oniga O; Tiperciuc B
Int J Mol Sci; 2018 Jan; 19(1):. PubMed ID: 29324679
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
